RTTNews | Aug 27, 2021 09:56AM EDT

09:56 Friday, August 27, 2021 (RTTNews.com) - Cassava Sciences, Inc. (SAVA) shares are trading down on Friday morning, continuing a slide since August 24, after a 'whistleblower submission' to FDA, questioning Cassava's study data on Alzheimer's testing.

In response, the company had said that these claims on scientific integrity are false and misleading. Currently, shares are at $57.41, down 18.96 percent from the previous close of $70.85 on a volume of 7,752,805. For the 52-week period, the shares have traded in a range of $2.78-$146.16 on average volume of 5,086,839.

Read the original article on RTTNews ( https://www.rttnews.com/3221606/cassava-sciences-continues-downslide.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved